Exagen (XGN) Q3 2026 Earnings Call Transcript
Management outlined new product launches and an AI acquisition aimed at deeper clinic integration.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
See Which Recent 13F Filers Hold LRCX But Eaton Cambridge Exited
At Holdings Channel, we have reviewed the latest batch of the 58 most recent 13F filings for the 09/30/2026 reporting period, and noticed that Lam Research Corp (Symbol: LRCX) was held by 25 of these…
Accenture vs. Adobe: What Does Fluctuating vs. Steady Revenue Tell Investors?
Key PointsAdobe currently demonstrates a stronger revenue trajectory with steady upward momentum across recent reporting periods, while Accenture continues to generate a higher total volume overall.
Are RCTs underpowered?
Maybe so: We study the statistical credibility of randomized controlled trials (RCTs) in development economics and the optimal allocation of resources to replication.
- Only 30% of published rejections are actual false discoveries
- Average directional power of RCTs at standard significance levels is 40%
- Doubling sample sizes reduces average false discovery rate by 5 percentage points
FG raises the alarm over carbide-ripened fruits, paracetamol-treated meat in markets
The Federal Government has raised an alarm over the use of harmful chemicals like calcium carbide to ripen fruits and paracetamol to soften meat in markets Read More…
Live: Wall Street retreats as hot inflation shortens odds of a rate hike, ASX set to slide
Wall Street hit the brakes as higher-than-expected inflation looks to have cemented a December rate hike, while the ASX is priced to slide as well.